William Blair Downgrades agilon health (NYSE:AGL) to Market Perform

agilon health (NYSE:AGL) was downgraded by research analysts at William Blair from an “outperform” rating to a “market perform” rating in a note issued to investors on Friday,Briefing.com Automated Import reports.

Several other research firms also recently weighed in on AGL. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. Citigroup restated a “sell” rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday, October 29th. Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Evercore ISI cut their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $7.81.

agilon health Stock Performance

NYSE AGL opened at $2.73 on Friday. The business’s 50-day moving average price is $3.31 and its 200 day moving average price is $5.00. agilon health has a twelve month low of $2.36 and a twelve month high of $13.76. The company has a market capitalization of $1.12 billion, a PE ratio of -3.74 and a beta of 0.60. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the business posted ($0.04) earnings per share. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year. On average, research analysts predict that agilon health will post -0.32 earnings per share for the current year.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. J.Safra Asset Management Corp lifted its holdings in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the last quarter. CWM LLC lifted its holdings in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in agilon health during the 2nd quarter worth approximately $60,000. Bleakley Financial Group LLC bought a new position in agilon health during the 1st quarter worth approximately $65,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after buying an additional 10,674 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.